|
ILMN | Illumina, Inc. |
| Laboratory Analytical Instruments |
| Book value per $ invested | $ 0.08 |
| Leverage | 57.32% |
| Market Cap | $ 33.9B |
| PE | 41.07 |
| Dividend Yield | 0.00% |
| Profit | $ 825.0m |
| Margin | 17.61% |
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.